Nachrichten zur Hims & Hers Health Inc. Aktie

Hims & Hers Health issues $402.5 million in convertible senior notes due 2032

Hims & Hers Health issues $402.5 million in convertible senior notes due 2032…

Hims & Hers Health Raises $402.5 Million Via 0% Convertible Notes; Adds Capped Calls at $50.15 Cap

Hims & Hers Health issued $402.5 million of 0.00% Convertible Senior Notes due 2032 under a new Indenture and entered…

Hims & Hers sells $402.5M 0% convertible notes

Hims & Hers raises $402.5M via 0% convertible notes due 2032, with a $29.53 conversion price, capped at $50.15 using…

Hims & Hers stock gains on Canada GLP-1 launch

Hims & Hers stock gains on Canada GLP-1 launch…

Hims Launches Canadian Semaglutide Offering As GLP-1 And Valuation Story Evolves

Hims & Hers Health (NYSE:HIMS) has launched generic semaglutide for weight loss in Canada as part of its international expansion.This…

The Silver Lining of Last Weeks Hims & Hers Earnings Miss

Hims & Hers plunged 23% after a major Q1 earnings miss, but long-term growth stays intact via its Novo Nordisk…

HIMS Launches Generic Semaglutide in Canada

On May 21, 2026, Hims & Hers Health (HIMS) announced the introduction of a generic version of semaglutide on its…

Hims & Hers launches generics for Novo’s semaglutide in Canada

Hims & Hers (HIMS) stock is in focus as the company launches generics targeting Novo Nordisks (NVO) semaglutide in Canada.…

Hims & Hers expands GLP-1 offering in Canada with generic Semaglutide

Hims Hers Health announced the availability of generic semaglutide through its platform in Canada. This is Hims Hers’…

Hims offers Apotexs generic semaglutide in Canada after Novo patent expiry

Hims & Hers Health said on Thursday it is now offering Canadians with type 2 diabetes a generic version of…

Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide…

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the availability of generic semaglutide…

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

SAN FRANCISCO, May 21, 2026--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the…

Hims & Hers Expands GLP-1 Offering in Canada with Generic Semaglutide

By introducing access to generic semaglutide in Canada, the company is meeting the needs of a dynamic market and continuing…

Hims & Hers Health Q1 2026: Strategic Shift to Branded Medications Weighs on Results

Hims & Hers Health posted Q1 2026 results on May 21, 2026, with revenue of $608.1M missing analyst estimates. A…

Eucalyptus acquisition prospect lifts Hims & Hers Health stock 2.67% higher

Hims & Hers Health rises 2.67% today, trading at $23.04 after a $350M note deal and strategic shifts support growth…

Hims & Hers Stock Slips As Dilution Fears Outweigh New Capital - Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health is trading flat on Wednesday as the stock continues to digest financing-related dilution risk and positioning…

Hims & Hers: Wegovy Deal Fuels Growth

Hims & Hers (HIMS) stock up 41% as Q1 revenue hits $608M and international sales surge 969% on ZAVA/Livewell deals.…

Hims & Hers Health, Inc.: Shareholders Board Members Managers and Company Profile | AR0162508391

Hims & Hers Health, Inc.: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Buenos…

Spotting Winners: Hims & Hers Health (NYSE:HIMS) And Healthcare Technology Stocks In Q1

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Hims &…

Hims & Hers CFO exercises options, sells 7,950 shares

Hims & Hers CFO Oluyemi Okupe exercised 7,950 options at $5.01 and sold 7,950 shares at $23.64 under a Rule…

Hims & Hers Health (HIMS) Is Down 23.5% After Zero-Coupon Convertible Note Offering

Earlier this month, Hims & Hers Health, Inc. completed a US$350 million offering of callable, senior unsecured zero-coupon convertible notes…

Hims & Hers Prices Upsized $350 Million Convertible Notes Offering

Hims & Hers increased its private offering from $300 million to support expansion, Eucalyptus acquisition plans, and technology investment.…

Hims & Hers Stock Stabilizes After Upsized $350 Million Convertible Note Offering - Hims & Hers Health (N

Hims & Hers Health (NYSE: HIMS) shares are trading flat in Tuesdays pre-market as traders continue to digest its convertible…

Hims & Hers Plans $300M Convertible Notes for Expansion

Hims & Hers Health ( ($HIMS) ) just unveiled an announcement. On May 18, 2026, Hims & Hers Health, Inc.…

Hims & Hers prices $350M 2032 convertible notes

Hims & Hers prices $350M of 0.00% convertible notes due 2032, plus a $52.5M option, to fund international expansion, the…

Hims & Hers price target lowered to $28 from $30 at BofA

BofA lowered the firm’s price target on Hims Hers to $28 from $30 and keeps a Neutral rating on…

Hims & Hers Health stock price forecast: $21.00 support as HIMS falls 11.02% to $22.29

Hims & Hers Health slides 11.02% to $22.29 today, pressured by weak results and debt offering amid ongoing business transition.…

HIMS stock slips overnight: Hims & Hers bulks up debt raise to $350M for Eucalyptus buyout, AI push

?The company expects net proceeds of up to $389.5 million from the debt offering. ?Hims’ $1.15 billion acquisition of Eucalyptus…

Hims & Hers Health (HIMS) Raises $350M in Convertible Notes Offering

On May 19, 2026, Hims & Hers Health Inc (HIMS) announced an increase in its private offering of 0.00% convertible…

Hims & Hers Health prices $350M senior convertible notes

Hims & Hers Health (HIMS) priced its offering of $350M aggregate principal amount of 0.00% convertible senior notes due 2032…

Hims & Hers prices $350 million convertible notes offering

Hims & Hers prices $350 million convertible notes offering…

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”, NYSE: HIMS) today announced the pricing of its offering…

Hims & Hers Falls on Planned $300 Million Convertible Debt Offering

Hims & Hers Health (HIMS, Financials) fell after the company proposed a private offering of $300 million in convertible senior…

Hims & Hers Health Drops 7.9% After B of A Securities Maintains Neutral

Shares of Hims & Hers Health, Inc. tumbled Monday, dropping 7.9% to $23.06 after a pair of Wall Street firms…

Hims & Hers Shares Slide After Convertible Notes Offering Announcement (HIMS)

Stock Drops Following Financing PlanShares of Hims & Hers Health (NYSE:HIMS) fell 7% on Monday after the company revealed plans…

Why Is Hims & Hers Stock Sinking Monday? - Hims & Hers Health (NYSE:HIMS)

HIMS shares drop 8% as Hims & Hers announces a $300M convertible notes offering, fueling investor dilution fears. Read more.…

Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead

Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters…

Forget Hims. Its CEO Dumped 436,000 Shares Before a 1,266% Earnings Miss. Here Is the Profitable Healthcare Stock to Own Instead

Hims & Hers (NYSE:HIMS) is dominating headlines this week because the GLP-1 darling just delivered one of the ugliest quarters…

HIMS: Hims & Hers Health Proposes $300M Convertible Notes Offering

On May 18, 2026, shares of Hims & Hers Health (HIMS) dropped nearly 4% in premarket trading following the announcement…

Hims & Hers Health, Inc. Prices Upsized $350 Million Convertible Senior Notes Offering to Support International Expansion and Accelerate AI-Driven Platform Investment

Proceeds intended to be used to preserve financial flexibility as Hims Hers executes on its international expansion strategy, including…

Hims & Hers Health Announces Proposed Convertible Senior Notes Offering To Support International Expansion And Accelerate AI-Driven Platform Investment

Hims & Hers Health Inc NYSE:HIMS:…

Hims & Hers seeks $300M in convertible debt for AI and global push

Proposed $300M notes, plus a $45M option, would fund Hims & Hers’ international expansion, proposed Eucalyptus deal by mid-2026, tech,…

dpa-AFX ProFeed